Iron Triangle Partners LP United Therapeutics Corp Transaction History

Iron Triangle Partners LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $2.25 Million - $2.64 Million	10,635 Added 5.32%	210,635 $47.6 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $41 Million - $46.6 Million	200,000 New	200,000 $44.2 Million
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $14.7 Million - $20.1 Million	71,576 New	71,576 $19.9 Million
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $33.2 Million - $45.8 Million	-190,073 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$166.16 - $213.96 $3.34 Million - $4.29 Million	20,073 Added 11.81%	190,073 $34.1 Million
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $18.4 Million - $21.6 Million	100,000 Added 142.86%	170,000 $36.7 Million
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $12.6 Million - $15 Million	70,000 New	70,000 $12.9 Million

673

42.2M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Iron Triangle Partners LP, based on Form 13F filings with the SEC.

Stay updated on Iron Triangle Partners LP with notifications on news.